[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100530550":3},{"organization":4,"outcomesModule":7,"designInfo":13,"detailedDescription":16,"studyPopulation":17,"armGroups":12,"interventions":12,"overallOfficials":18,"centralContacts":23,"locations":29,"responsibleParty":44,"collaborators":12,"id":46,"slug":12,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":12,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":12,"enrollmentInfo":54,"targetDuration":12,"studyType":57,"phases":12,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":32,"whyStopped":12,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Hanlim Pharm. Co., Ltd.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":12,"otherOutcomes":12},[9],{"measure":10,"description":10,"timeFrame":11},"Change in HbA1c at 6 months of prescribing Tenero Tablet\u002FTenero Emextended Release Tablet compared to baseline","after 6 months of prescription for Tenero Tab\u002FTenero M SR Tab compared to baseline",null,{"allocation":12,"interventionModel":12,"interventionModelDescription":12,"primaryPurpose":12,"observationalModel":14,"timePerspective":15,"maskingInfo":12},"CASE_ONLY","PROSPECTIVE","This study is to observe the clinical efficacy by analyzing the prescription patterns in routine clinical practice and changes in HbA1c, FPG, PP2G, etc., of patients prescribed with Tenero Tab\u002FTenero M SR Tab for diabetes treatment. Additionally, the study intends to assess patient satisfaction based on these observations.","Patients prescribed Tenero Tab\u002FTenero M SR Tab for diabetes treatment.",[19],{"name":20,"affiliation":21,"role":22},"Seokgi Yoon","CHEONAN ENDO MEDICAL CLINIC","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":12,"email":28},"Yeonhwa Kim","CONTACT","82-2-3489-6163","yh@hanlim.com",[30],{"facility":31,"status":32,"city":33,"state":12,"zip":12,"country":34,"countryCode":12,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Cheonan Endo Medical Clinic","RECRUITING","Cheonan","South Korea",{"type":36,"coordinates":37},"Point",[38,39],127.1522,36.8065,{"lat":39,"lon":38},[42],{"name":20,"role":26,"phone":43,"phoneExt":12,"email":12},"82-41-592-7201",{"type":45,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR","100530550",false,"NCT06188234","The Prescription Patterns and Clinical Efficacy of Tenero Tab\u002FTenero M SR Tab","Observational Study on the Prescription Patterns and Clinical Efficacy of Tenero Tab\u002FTenero M SR Tab in Korean Type 2 Diabetes Mellitus Patients","Inclusion Criteria:\n\n1. Adults over 19 years of age\n2. Individuals diagnosed with type 2 diabetes.\n3. Individuals who, at the clinical discretion, are prescribed Tenero Tab or Tenero M SR Tab for the purpose of diabetes treatment for the first time.\n4. Individuals who have voluntarily provided written consent to participate in this study.\n\nExclusion Criteria:\n\n1. Pregnant or breastfeeding women.\n2. Individuals who are contraindicated according to the approved indications of Tenero Tab\u002FTenero M SR Tab.\n3. Other cases where the principal investigator and study personnel deem individuals ineligible for participation in this clinical trial.","ALL","19 Years",{"count":55,"type":56},3000,"ESTIMATED","OBSERVATIONAL","This study is to observe the prescription patterns and clinical efficacy of patients prescribed with Tenero Tab\u002FTenero M SR Tab for diabetes treatment in routine clinical practice.",[60],"Diabetes Mellitus, Type 2",[62,63],"Metformin HCI","Teneligliptin hydrochloride","2024-02-13",{"date":66,"type":67},"2024-02-15","ACTUAL",{"date":69,"type":67},"2022-12-27",{"date":71,"type":56},"2026-06",{"name":5,"class":6},1]